As of June 30, 2025, Ulvac, Inc. carries a market capitalization of 1.68B, placing it among publicly traded companies globally. Its enterprise value stands at 1.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.68B |
| Enterprise Value | 1.32B |
Ulvac, Inc.'s next confirmed earnings release is scheduled for November 10, 2026.
| Earnings Date | 11/10/2026 |
As of June 30, 2025, Ulvac, Inc. has 49.24M shares outstanding.
| Shares Outstanding | 49.24M |
These figures are as of June 30, 2025.
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.11 |
As of June 30, 2025, Ulvac, Inc. maintains a current ratio of 2.68, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.68 |
| Quick Ratio | 1.05 |
| Debt / Equity | 20.17 |
These figures cover the twelve months ended June 30, 2025.
| Employee Count | 6,208.50 |
Over the twelve months ended June 30, 2025, Ulvac, Inc. recorded 11.77M in income tax expense.
| Income Tax | 11.77M |
As of the close on October 14, 2026, Ulvac, Inc.'s stock has gained approximately 60.58% over the past 52 weeks.
| 52-Week Price Change | 60.58% |
As of June 30, 2025, Ulvac, Inc. holds 735.68M in cash and equivalents against 323.57M in total debt, resulting in a net debt position of -394.56M. Total book value stands at 1.55B, with working capital of 1.18B providing operational flexibility.
| Cash & Cash Equivalents | 735.68M |
| Total Debt | 323.57M |
| Net Debt | -394.56M |
| Equity (Book Value) | 1.55B |
| Book Value Per Share | 31.51 |
| Working Capital | 1.18B |
These figures cover the twelve months ended June 30, 2025.
| Capital Expenditures | -34.34M |
Already premium?